Standout Papers
- Randomized Trial Comparing a Web-Mediated Follow-up With Routine Surveillance in Lung Cancer Patients (2017)
- The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline (2022)
- Two-Year Survival Comparing Web-Based Symptom Monitoring vs Routine Surveillance Following Treatment for Lung Cancer (2019)
- Final Results of the 94–01 French Head and Neck Oncology and Radiotherapy Group Randomized Trial Comparing Radiotherapy Alone With Concomitant Radiochemotherapy in Advanced-Stage Oropharynx Carcinoma (2003)
Immediate Impact
1 from Science/Nature 64 standout
Citing Papers
Principles and therapeutic applications of adaptive immunity
2024 Standout
Polymeric Nanoparticles for Drug Delivery
2024 Standout
Works of Fabrice Denis being referenced
LBA47 Activity of OSE-2101 in HLA-A2+ non-small cell lung cancer (NSCLC) patients after failure to immune checkpoint inhibitors (IO): Final results of phase III Atalante-1 randomised trial
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Fabrice Denis | 866 | 1227 | 739 | 810 | 108 | 3.2k | |
| Henry S. Park | 1521 | 1253 | 1157 | 646 | 169 | 4.2k | |
| Sang-wook Lee | 1084 | 894 | 1219 | 591 | 176 | 3.5k | |
| Carin A. Uyl‐de Groot | 880 | 1406 | 387 | 235 | 212 | 3.6k | |
| Charlotte Jacobs | 715 | 1534 | 867 | 1076 | 66 | 3.3k | |
| Andrew G. Shuman | 486 | 634 | 604 | 661 | 159 | 2.4k | |
| Peter A.S. Johnstone | 1336 | 1397 | 1377 | 385 | 169 | 4.2k | |
| James D. Murphy | 2042 | 1780 | 1244 | 559 | 263 | 5.0k | |
| Michel Velten | 860 | 1936 | 873 | 314 | 172 | 4.5k | |
| Gianmauro Numico | 764 | 1123 | 523 | 529 | 113 | 2.5k | |
| Arvin S. Glicksman | 1073 | 1023 | 706 | 189 | 143 | 3.4k |
All Works
Login with ORCID to disown or claim papers
Loading papers...